Metabolic Disorders The recommended dose is 50 mg/kg given as a slow 2-3 minute bolus injection or by infusion
Actual dosing decisions depend on provider evaluation, patient tolerance, and treatment goals
We verified the impact of ACTL6A on GSH synthesis and confirmed that ACTL6A KD led to reduced expression of certain genes (GCLC, GPX2, GPX4, SLC7A11, SLC1A5, GSS, GLS, etc.) involved in the GSH synthesis pathway (Supplementary Fig
Note: These services and products are not intended to diagnose, treat, cure or prevent any disease
Presently developed pro-senescence therapies concentrate on the deliberate induction of cellular senescence [7]
Beyond its antioxidant role, it also supports the immune system and helps the liver process and remove toxins